Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
The advent of induced pluripotent stem cells (iPSCs) has begun to revolutionize cell therapy by providing a convenient source of rare cell types not normally available from patients in sufficient numbers for therapeutic purposes. In particular, the development of protocols for the differentiation of...
Príomhchruthaitheoirí: | Sachamitr, P, Leishman, A, Davies, T, Fairchild, P |
---|---|
Formáid: | Journal article |
Foilsithe / Cruthaithe: |
Frontiers Media
2018
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141 XCR1 dendritic cells
de réir: Silk, K, et al.
Foilsithe / Cruthaithe: (2012) -
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
de réir: Silk, K, et al.
Foilsithe / Cruthaithe: (2012) -
Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype.
de réir: Silk, K, et al.
Foilsithe / Cruthaithe: (2012) -
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
de réir: Sachamitr, P, et al.
Foilsithe / Cruthaithe: (2014) -
Tolerogenicity is not an absolute property of a dendritic cell.
de réir: Farquhar, C, et al.
Foilsithe / Cruthaithe: (2010)